Home Cart Sign in  
Chemical Structure| 230615-23-3 Chemical Structure| 230615-23-3

Structure of Varenicline HCl
CAS No.: 230615-23-3

Chemical Structure| 230615-23-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Varenicline HCl is a nicotinic receptor partial agonist and it stimulates nicotine receptors more weakly than nicotine itself does.

Synonyms: CP 526555 hydrochloride; Varenicline Hydrochloride

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Varenicline HCl

CAS No. :230615-23-3
Formula : C13H14ClN3
M.W : 247.72
SMILES Code : [H]Cl.C1(C2)CNCC2C3=CC4=NC=CN=C4C=C13
Synonyms :
CP 526555 hydrochloride; Varenicline Hydrochloride
MDL No. :MFCD11042277

Safety of Varenicline HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01574703 Smoking Cessation Phase 4 Completed - -
NCT02744417 Periodontitis Not Applicable Completed - -
NCT02582008 Current Smoker ... More >> Head and Neck Squamous Cell Carcinoma Hypopharyngeal Squamous Cell Carcinoma Laryngeal Squamous Cell Carcinoma Nasopharyngeal Carcinoma Oral Cavity Squamous Cell Carcinoma Oropharyngeal Squamous Cell Carcinoma Less << Early Phase 1 Recruiting January 2020 United States, North Carolina ... More >> Wake Forest University Health Sciences Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Mercedes Porosnicu    336-716-8664    mporosni@wakehealth.edu    Principal Investigator: Mercedes Porosnicu          United States, South Carolina Medical University of South Carolina Not yet recruiting Charleston, South Carolina, United States, 29425 Contact: Graham Warren    843-876-2295    warrengw@musc.edu    Principal Investigator: Graham Warren Less <<
NCT02146911 Tobacco Use Disorder ... More >> Nicotine Dependence Less << Not Applicable Completed - Canada, Ontario ... More >> Centre for Addiction and Mental Health, Nicotine Dependence Clinic Toronto, Ontario, Canada, M5T 1P7 Less <<
NCT01574703 - Completed - -
NCT01456936 Smoking Cessation Phase 4 Completed - -
NCT01456936 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.04mL

0.81mL

0.40mL

20.18mL

4.04mL

2.02mL

40.37mL

8.07mL

4.04mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories